<SEC-DOCUMENT>0001213900-25-022756.txt : 20250311
<SEC-HEADER>0001213900-25-022756.hdr.sgml : 20250311
<ACCEPTANCE-DATETIME>20250311163018
ACCESSION NUMBER:		0001213900-25-022756
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250311
DATE AS OF CHANGE:		20250311

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Columbus Acquisition Corp/Cayman Islands
		CENTRAL INDEX KEY:			0002028201
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94809
		FILM NUMBER:		25728053

	BUSINESS ADDRESS:	
		STREET 1:		89 NEXUS WAY
		STREET 2:		CAMANA BAY
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-9009
		BUSINESS PHONE:		212-451-2930

	MAIL ADDRESS:	
		STREET 1:		89 NEXUS WAY
		STREET 2:		CAMANA BAY
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-9009

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hercules Capital Management VII Corp
		CENTRAL INDEX KEY:			0002046110
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		RITTER HOUSE, WICKHAMS CAY II
		STREET 2:		PO BOX 3170, ROAD TOWN
		CITY:			TORTOLA
		STATE:			D8
		ZIP:			VG1110
		BUSINESS PHONE:		949 899 1827

	MAIL ADDRESS:	
		STREET 1:		RITTER HOUSE, WICKHAMS CAY II
		STREET 2:		PO BOX 3170, ROAD TOWN
		CITY:			TORTOLA
		STATE:			D8
		ZIP:			VG1110
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0001213900-25-006669</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Hercules Capital Management VII Corp -->
          <cik>0002046110</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Ordinary Share, par value $0.0001 per share</securitiesClassTitle>
      <dateOfEvent>03/10/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0002028201</issuerCIK>
        <issuerCUSIP>G2295P107</issuerCUSIP>
        <issuerName>Columbus Acquisition Corp/Cayman Islands</issuerName>
        <address>
          <com:street1>89 NEXUS WAY, CAMANA BAY</com:street1>
          <com:street2>GRAND CAYMAN</com:street2>
          <com:city>CAYMAN ISLANDS</com:city>
          <com:stateOrCountry>KY</com:stateOrCountry>
          <com:zipCode>1-9009</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Fen Zhang CEO</personName>
          <personPhoneNum>19498991827</personPhoneNum>
          <personAddress>
            <com:street1>14 Prudential Tower,</com:street1>
            <com:city>Singapore</com:city>
            <com:stateOrCountry>U0</com:stateOrCountry>
            <com:zipCode>049712</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002046110</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Hercules Capital Management VII Corp</reportingPersonName>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>D8</citizenshipOrOrganization>
        <soleVotingPower>1698290.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1698290.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>1698290.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>21.4</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>(1) It includes (i) 234,290 ordinary shares, par value $0.0001 per share of the Issuer (the "Ordinary Shares") that Hercules Capital Management VII Corp (the "Sponsor") acquired in a private placement simultaneously with the consummation of the initial public offering on January 24, 2025, and (ii) 1,464,000Ordinary Shares that the Sponsor acquired on March 21, 2024.

(2) The Sponsor is the record holder of the shares reported herein. Dr. Fen Zhang is the sole director of the Sponsor. As such, Dr. Zhang is deemed to hold voting and dispositive control over the securities held directly by the Sponsor.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0002026975</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Fen Zhang</reportingPersonName>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>Z4</citizenshipOrOrganization>
        <soleVotingPower>1698290.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1698290.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>1698290.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>21.4</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>(3) Dr. Fen Zhang is the sole director of the Sponsor. As such, Dr. Zhang is deemed to hold voting and dispositive control over the securities held directly by the Sponsor.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Ordinary Share, par value $0.0001 per share</securityTitle>
        <issuerName>Columbus Acquisition Corp/Cayman Islands</issuerName>
        <issuerPrincipalAddress>
          <com:street1>89 NEXUS WAY, CAMANA BAY</com:street1>
          <com:street2>GRAND CAYMAN</com:street2>
          <com:city>CAYMAN ISLANDS</com:city>
          <com:stateOrCountry>KY</com:stateOrCountry>
          <com:zipCode>1-9009</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed by Hercules Capital Management VII Corp, a British Virgin Islands company (the "Sponsor") and Dr. Fen Zhang ("Dr. Zhang", together with the Sponsor, the "Reporting Persons"). The Reporting Persons are the holders of record of approximately 21.4% of the Issuer's outstanding Ordinary Shares based on the number of Ordinary Shares outstanding as of March 10, 2025.</filingPersonName>
        <principalBusinessAddress>The principal business address of the Sponsor is 14 Prudential Tower, Singapore, 049712. The principal business address of Dr. Fen Zhang is c/o Columbus Acquisition Corp, 14 Prudential Tower, Singapore, 049712.</principalBusinessAddress>
        <principalJob>The Sponsor is the sponsor of the Issuer and primarily involved in investment. Dr. Zhang is the sole director of the Sponsor.</principalJob>
        <hasBeenConvicted>During the past five years, none of the Reporting Persons or to the knowledge of the Reporting Persons, the persons identified in this Item 2, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the past five years, none of the Reporting Persons or to the knowledge of the Reporting Persons, the persons identified in this Item 2, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was the subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal and state securities laws of findings any violation with respect to such laws.</convictionDescription>
        <citizenship>The Sponsor is a company incorporated in British Virgin Islands. The citizenship of Dr. Zhang is Canada.</citizenship>
      </item2>
      <item3>
        <fundsSource>The information set forth in Items 4 and 5 of this Schedule 13D are hereby incorporated by reference into this Item 3.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>Pursuant to a subscription agreement dated March 21, 2024, as further amended on July 25, 2024 and December 20, 2024 (the "Subscription Agreement"), the Sponsor acquired 1,725,000 Ordinary Shares for an aggregated purchase price of $25,000, including 225,000 Ordinary Shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Immediately prior to the closing of the initial public offering of the Issuer (the "IPO"), the Sponsor transferred 36,000 Ordinary Shares to certain directors of the Issuer at its original purchase price pursuant to a securities transfer agreement among the Sponsor, the Issuer and certain directors of the Issuer. On January 24, 2025, simultaneously with the initial public offering of the Issuer, the Sponsor acquired 234,290 units at $10.00 per unit, each unit consisting of one Ordinary Share and one right. Each right entitles the holder to acquire one-seventh of one Ordinary Share at the competion of an initial business combination of the Issuer.

On March 10, 2025, the Sponsor forfeited 225,000 Ordinary Shares pursuant the Subscription Agreement for no consideration, as the underwriters of the IPO did not exercise the over-allotment option within 45-days from the effective date of the Issuer's Registration Statement on Form S-1 (File No. 333-283278), which was declared effective on January 22,  2025.

Depending on prevailing market, economic and other conditions, the Reporting Persons may from time to time acquire additional Ordinary Shares or engage in discussions with the Issuer concerning future acquisitions of its shares. Such acquisitions may be made by means of open-market purchases, privately negotiated transactions, direct acquisitions from the Issuer or otherwise.

Except as set forth in this Item 4, the Reporting Persons have no plans or proposals that relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present Board or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the Board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure, including but not limited to, if the issuer is a registered closed-end investment company; (g) changes in the Issuer's charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or (j) any action similar to any of those enumerated above. The Reporting Persons may, at any time and from time to time, formulates other purposes, plans or proposals regarding the Issuer, or any other actions that could involve one or more of the types of transactions or have one or more of the results described in clauses (a) through (j) of Item 4 of Schedule 13D.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>The responses to Items 7 - 13 of the cover pages of this Schedule 13D are incorporated herein by reference. The aggregate number and percentage of Ordinary Shares beneficially or directly owned by the Reporting Persons is based upon a total of 7,944,290 Ordinary Shares outstanding as of March 10, 2025 (excluding 225,000 Ordinary Shares forfeited by the Sponsor as described herein). The Reporting Persons beneficially own 1,698,290 Ordinary Shares, representing approximately 21.4% issued and outstanding Ordinary Shares.</percentageOfClassSecurities>
        <numberOfShares>The responses to Items 7 - 13 of the cover pages of this Schedule 13D are incorporated herein by reference. The beneficial ownership of the Reporting Persons is 1,698,290 Ordinary Shares, representing approximately 21.4% issued and outstanding Ordinary Shares.</numberOfShares>
        <transactionDesc>Other than the disposition of the shares as reported in this Schedule 13D, no actions in the Ordinary Shares were effected during the past sixty (60) days by the Reporting Persons.</transactionDesc>
        <listOfShareholders>N/A</listOfShareholders>
        <date5PercentOwnership>N/A</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>The information set forth in Items 4 of this Schedule 13D are hereby incorporated by reference into this Item 6.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Item 7 of the Schedule 13D is hereby amended by adding the following to the end of the section:

7.1 - Joint Filling Agreement, dated March 11, 2025

10.1 - Securities Transfer Agreement dated November 8, 2024, as amended on December 20, 2024, by and among the Issuer, the Sponsor and certain directors of the Issuer

10.2 - Private Placement Units Purchase Agreement dated January 22, 2025, between the Sponsor and the Issuer.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Hercules Capital Management VII Corp</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fen Zhang</signature>
          <title>Fen Zhang/Sole Director</title>
          <date>03/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Fen Zhang</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fen Zhang</signature>
          <title>Fen Zhang</title>
          <date>03/11/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-7.1
<SEQUENCE>2
<FILENAME>ea023382303ex7-1_columbus.htm
<DESCRIPTION>JOINT FILLING AGREEMENT, DATED MARCH 10, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 7.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">JOINT FILING AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
undersigned agree that this Schedule 13D/A, and any amendments hereto, relating to the ordinary shares, par value of US$0.0001 per share
of <B>Columbus Acquisition Corp</B>, a Cayman Islands company whose principal place of business is in Singapore shall be filed on behalf
of the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 11, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Hercules Capital Management VII Corp</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Fen Zhang</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fen Zhang</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fen Zhang</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt">/s/ Fen Zhang</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
